Method for using a refrigeration system to remove waste heat from an ultrasound transducer
    2.
    发明申请
    Method for using a refrigeration system to remove waste heat from an ultrasound transducer 审中-公开
    使用制冷系统从超声换能器去除废热的方法

    公开(公告)号:US20060173344A1

    公开(公告)日:2006-08-03

    申请号:US11039588

    申请日:2005-01-19

    IPC分类号: A61B8/14

    摘要: Methods and systems are provided for cooling an ultrasound transducer using a refrigeration system located within the imaging system. A closed loop of recirculating coolant located in the transducer assembly transports waste heat from the remotely located heat producing acoustic components or active electronics components to a thermally conductive shoe, located within the transducer connector. Thermally conductive materials in each connector, the ultrasound system connector and the transducer assembly connector, are positioned in contact to thermally conduct heat from the transducer assembly to a refrigeration system, located in the imaging system, free of fluid transfer.

    摘要翻译: 提供了用于使用位于成像系统内的制冷系统来冷却超声换能器的方法和系统。 位于换能器组件中的再循环冷却剂的闭环将来自远程位于发热的声学组件或有源电子部件的废热传送到位于换能器连接器内的导热靴。 每个连接器中的导热材料,超声系统连接器和换能器组件连接器被定位成接触,以将来自换能器组件的热量传导到位于成像系统中的没有流体转移的制冷系统。

    INHIBITORS OF SERINE PALMITOYLTRANSFERASE
    3.
    发明申请
    INHIBITORS OF SERINE PALMITOYLTRANSFERASE 审中-公开
    丝氨酸蛋白酶抑制剂的抑制剂

    公开(公告)号:US20080287479A1

    公开(公告)日:2008-11-20

    申请号:US11945452

    申请日:2007-11-27

    CPC分类号: C07D401/04 C07D401/14

    摘要: This invention provides compounds of the formula: useful in the inhibition or modulation of serine palmitoyl transferase and their use in methods of treatment or amelioration of type 2 diabetes, type 1 diabetes, insulin resistance, the effects of obesity, metabolic syndrome (sometimes referred to as Syndrome X), impaired glucose tolerance, Cushing's disease, cardiovascular disease, prothrombotic conditions, myocardial infarction, hypertension, congestive heart failure, cardiomyopathy, atherosclerosis, dyslipidemia, sepsis, liver damage, retinal degenerative disorders, cachexia, emphysema, hepatitis C infections, HIV infections and inflammatory disorders and useful in methods for raising HDL plasma levels in a mammal. The compounds of this invention can also be used to prevent damage or loss of pancreatic islet beta cells (such as in the case of pancreatic beta cell apoptosis, including those related to insulin-dependent diabetes mellitus).

    摘要翻译: 本发明提供下式的化合物:可用于抑制或调节丝氨酸棕榈酰转移酶及其在治疗或改善2型糖尿病,1型糖尿病,胰岛素抵抗,肥胖症,代谢综合征(有时称为 作为综合征X),葡萄糖耐量减低,库欣氏病,心血管疾病,血栓形成状况,心肌梗死,高血压,充血性心力衰竭,心肌病,动脉粥样硬化,血脂异常,败血症,肝损伤,视网膜退行性疾病,恶病质,肺气肿,丙型肝炎感染, HIV感染和炎症性疾病,并且可用于在哺乳动物中提高HDL血浆水平的方法。 本发明的化合物也可用于防止胰岛β细胞的损伤或损失(例如在胰腺β细胞凋亡的情况下,包括与胰岛素依赖性糖尿病相关的细胞凋亡)。

    SUBSTITUTED (S)-BENZOXAZINONES
    8.
    发明申请
    SUBSTITUTED (S)-BENZOXAZINONES 审中-公开
    取代(S) - 苯并恶嗪酮

    公开(公告)号:US20090311318A1

    公开(公告)日:2009-12-17

    申请号:US12484119

    申请日:2009-06-12

    CPC分类号: A61K31/538 C07D413/10

    摘要: The present invention provides enantiomerically pure substituted (S)-benzoxazinone compounds and an extended release formulation of the compounds. The compounds exhibit potent renin inhibition activities and improved bioavailability.

    摘要翻译: 本发明提供对映体纯的取代的(S) - 苯并恶嗪酮化合物和化合物的延长释放制剂。 该化合物显示出有效的肾素抑制活性和改善的生物利用度。